TürkiyeDiagnosis and screening
Genetic testing in 50 patients with Stargardt disease in Ankara: diagnosis confirmed in more than half
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
In Ankara, the genetic test results of patients diagnosed with Stargardt disease were reviewed. The study included 50 patients from 46 families. Genetic testing confirmed the diagnosis in 54% of patients. The diagnosis changed in 10%, and the result was inconclusive in 36%. Test results and counseling were completed in an average of 6.9 months.
What does it mean for patients and families?
Genetic testing can help give the eye disease its exact name. This is also important for joining gene studies that may open in the future. The result may not be clear for every patient.
Source
Scientific paper: Contribution of genetic test results to patient management in ophthalmology: results from a Turkish Stargardt disease cohort. Turkish Journal of Medical Sciences, 2025. DOI: 10.55730/1300-0144.6077 · PubMed 41234456
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Stargardt disease
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.